Mycomagic Biotech. is committed to unlocking the biomedical protein, FIP-GMI, for decades. Our strategy is to strive for the innovative product a solution applied from pharmaceutical (MM767593), nutraceutical (Reishimmune@) ,cosmetics (Lumiderma) to pet food (New RS Protein).GMI has been shown to alleviate COVID-19 infection and the potential severe cases led by the cytokine storm. This work won a gold medal in theMoscow International Salon of Industrial Property "Archimedes" this year.
| Sales markets | Asia |
|---|---|
| Primary business activity | Manufacturer: Ingredients / Additives |
| Affiliated categories: | Reishi More |